{"DataElement":{"publicId":"2004671","version":"3","preferredName":"Cardiovascular Disease Present Ind-2","preferredDefinition":"the yes/no indicator that asks whether the patient has a history of cardiovascular disease.","longName":"CARDIO_DZ_PRES_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2526323","version":"1","preferredName":"Cardiovascular Disease Present","preferredDefinition":"information related to the any abnormal condition of the heart or blood vessels that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person being found.","longName":"CV_DZ_PRES","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2527214","version":"1","preferredName":"Cardiovascular Diseases and Disorders","preferredDefinition":"Cardiovascular; pertaining to the heart or blood vessels.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C25292:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular","conceptCode":"C25292","definition":"Pertaining to the heart or blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F8EB52C-D6DA-14DD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-11","modifiedBy":"ONEDATA","dateModified":"2006-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F64B1E7-685F-5041-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104894","version":"1","longName":"GOG-0231D","context":"NRG"},{"publicId":"4104895","version":"1","longName":"GOG-0238","context":"NRG"},{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104888","version":"1","longName":"GOG-0209","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"10000078","version":"1","longName":"GOG-0186H","context":"NRG"},{"publicId":"10000077","version":"1","longName":"GOG-0186H","context":"NRG"},{"publicId":"4104904","version":"1","longName":"GOG-0186H","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"10000693","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"4104931","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"10000692","version":"1","longName":"GOG-9923","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104938","version":"1","longName":"GOG-0254","context":"NRG"},{"publicId":"4104940","version":"1","longName":"GOG-0268","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"CARDIO_DZ_PRES_IND2","type":"USED_BY","context":"Alliance"},{"name":"CARDIO_DZ_PRES_IND2","type":"USED_BY","context":"NRG"},{"name":"CARDIO_DZ_PRES_IND2","type":"USED_BY","context":"CITN"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"BASCARD","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Has the patient suffered card","type":"Preferred Question Text","description":"Has the patient suffered cardiovascular disease?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Does the patient have a history of cardiovascular disease","url":null,"context":"CTEP"},{"name":"Cardiac Disease History","type":"Alternate Question Text","description":"Cardiac Disease History","url":null,"context":"CTEP"},{"name":"Does the patient have a history of myocardial infarction within 6 months before enrollment, New York Heart Association (NYHA) Class II or greater heart failure or symptoms suspicious for congestive heart failure","type":"Alternate Question Text","description":"Does the patient have a history of myocardial infarction within 6 months before enrollment, New York Heart Association (NYHA) Class II or greater heart failure or symptoms suspicious for congestive heart failure","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Did the patient experience a myocardial infarction within the past 6 months, Class III or IV heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Cardiovascular Disease","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Does the patient have New York Heart Association Grade II or greater congestive heart failure","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Using New York Heart Association (NYHA) guidelines, does the patient have Grade II or greater congestive heart failure or serious cardiac arrhythmia requiring medication? ","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Does the patient have a history with symptomatic congestive heart failure of New York Heart Association Class III or IV (See Appendix III), unstable angina pectoris, symptomatic congestive heart failure, myocardial infarction <=6 months of start of study drug, serious uncontrolled cardiac arrhythmia or any other clinically significant disease? ","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Patients may not have any clinically significant cardiovascular disease including the following: myocardial infarction or ventricular tachyarrhythmia within 6 months, prolonged QTc >=480 msec (Fridericia correction), ejection fraction less than institutional normal, or major conduction abnormality (unless a cardiac pacemaker is present)","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Did the patient experience a myocardial infarction within the past 6 months, New York Heart Association (NYHA) Class III or IV heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Does the patient have a significant history of cardiac disease, i.e., uncontrolled hypertension, unstable angina, congestive heart failure or uncontrolled arrhythmias within 6 months of today's date?","url":null,"context":"CTEP"},{"name":"CRF Text14","type":"Alternate Question Text","description":"Did the patient experience a myocardial infarction within the past 6 months, or have New York Heart Association (NYHA) Class III or IV heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities?","url":null,"context":"CTEP"},{"name":"CRF Text15","type":"Alternate Question Text","description":"Does the patient have clinically significant cardiovascular disease?","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Does the patient have adequately controlled hypertension, and no prior history of hypertensive crisis or hypertensive encephalopathy?","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Does the patient have inadequately controlled hypertension, or any prior history of hypertensive crisis or hypertensive encephalopathy?","url":null,"context":"CTEP"},{"name":"CRF Text17","type":"Alternate Question Text","description":"Does the patient have a history or evidence of cardiovascular risk, including any of the following: QTcB greater than or equal to 480 msec or history or evedience of current clinically significant uncontrolled arrhythmias?","url":null,"context":"CTEP"},{"name":"CRF Text18","type":"Alternate Question Text","description":"Cardiovascular disease that meets one of the following: congestive heart failure (New York Association Class III or IV), active angina pectoris, or recent myocardial infarction (within the last 6 months).","url":null,"context":"CTEP"},{"name":"CRF Text16","type":"Alternate Question Text","description":"Has the patient had clinically significant cardiovascular disease (e.g. uncontrolled hypertension, MI or unstable angina within 6 months prior to registration); NYHA grade II or greater CHF, serious cardiac arrhythmia requiring medication, or grade II or greater peripheral vascular disease?","url":null,"context":"CTEP"},{"name":"CVD","type":"Alternate Question Text","description":"Has anyone ever said you have Cardiovascular Disease?","url":null,"context":"NCIP"},{"name":"CRF Text 19","type":"Alternate Question Text","description":"Cardiovascular disease that meets one of the following: congestive heart failure (New York Heart Association Class III or IV), active angina pectoris, or recent myocardial infarction or acute coronary syndrome (within the last 6 months)","url":null,"context":"CTEP"},{"name":"CRF Text13","type":"Alternate Question Text","description":"History of congestive heart failure (CHF) with New York Heart Association (NYHA) Class III or IV","url":null,"context":"CTEP"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Severe cardiovascular disease, i.e. arrhythmias requiring chronic treatment, congestive heart failure (NYHA Class III or IV) or symptomatic ischemic heart disease","url":null,"context":"CTEP"},{"name":"NRG_CRF Text 2","type":"Alternate Question Text","description":"Using the New York Heart Association guideline provided in Appendix IV, does the patient have Grade II or greater congestive heart failure?","url":null,"context":"NRG"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Does the patient have a history of cardiac disease including uncontrolled angina, congestive heart failure, or myocardial infarction, congenital long QT syndrome, clinical significant ventricular arrhythmias within six months prior to study entry?","url":null,"context":"NRG"},{"name":"NRG_CRF Text2","type":"Alternate Question Text","description":"Does the patient have a history or evidence of cardiovascular risk, including any of the following: LVEF< LLN, a QTcB greater than or equal to 480 msec or history or evidence of current clinically significant uncontrolled arrhythmias?","url":null,"context":"NRG"},{"name":"CRF_Text_20","type":"Alternate Question Text","description":"Does the patient have known inadequately controlled hypertension; clinically significant pulmonary disease including dyspnea at rest, or patients requiring supplemental oxygen, or poor pulmonary reserve; proteinuria or clinically significant renal function impairment (baseline serum creatinine > 2mg/dL); or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"CTEP"},{"name":"NRG_CRF Text 4","type":"Alternate Question Text","description":"Does the patient have a history of congestive heart failure or cardiovascular disease or history of exposure to cardiotoxic agents who are not already excluded per Section 3.3.5?","url":null,"context":"NRG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have congenital long QT syndrome, history of ventricular arrhythmias or heart block?","url":null,"context":"COG"},{"name":"CRF Text 23","type":"Alternate Question Text","description":"Does the patient have asymptomatic arrhythmia?","url":null,"context":"CTEP"},{"name":"CRF Text 24","type":"Alternate Question Text","description":"Does the patient have symptomatic arrhythmia?","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Does the patient have cardiopulmonary disease","url":null,"context":"COG"},{"name":"CRF Text26","type":"Alternate Question Text","description":"Prior clinically significant cardiac arrhythmia?","url":null,"context":"Alliance"},{"name":"CRF Text25","type":"Alternate Question Text","description":"Prior class III or IV congestive heart failure?","url":null,"context":"Alliance"},{"name":"CRF Text 25","type":"Alternate Question Text","description":"Does the patient have cardiac disease (history of and/or active disease) that would preclude the use of the drugs included in the treatment regimens?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Does the patient have uncontrolled cardiac disease, as defined per protocol criteria 3.2.9, that would preclude the use of any of the drugs included in GI005 treatment in the opinion of the treating medical oncologist?","url":null,"context":"NRG"},{"name":"ABTC 1802 Text 1","type":"Alternate Question Text","description":"Does the patient have a history or presence of clinically significant cardiac arrhythmias (including resting bradycardia, uncontrolled atrial fibrillation, or uncontrolled paroxysmal supraventricular tachycardia)? ","url":null,"context":"ABTC"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have known inadequately controlled hypertension; clinically significant pulmonary disease including dyspnea at rest, or patients requiring supplemental oxygen, or poor pulmonary reserve; or clinically significant renal function impairment (baseline serum creatinine > 2mg/dL); or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Does the patient have uncontrolled cardiac disease, as defined per protocol criteria 3.2.10, that would preclude the use of any of the drugs included in GI005 treatment in the opinion of the treating medical oncologist?","url":null,"context":"NRG"},{"name":"CRF Text28","type":"Alternate Question Text","description":"Does the patient have poorly controlled hypertension or congestive heart failure at registration?","url":null,"context":"Alliance"},{"name":"CRF Text27","type":"Alternate Question Text","description":"NYHA Heart Failure","url":null,"context":"Alliance"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Does the patient have known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents?","url":null,"context":"NRG"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"Cardiovascular disease","url":null,"context":"AMC"},{"name":"NRF_CRF_Text_5","type":"Alternate Question Text","description":"Does patient have history of myocardial infarction, stroke, or transient ischemic attack in the past 3 months?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC06F8B4-A2B6-730D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-01","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-02","modifiedBy":"CLOHNES","dateModified":"2023-02-14","changeDescription":"Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2/14/23 added AQT for NRG ticket number CADSR0002048 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}